Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03690375 · ClinicalTrials.gov registry record · NA
Broad Band Light for the Treatment and Prevention of Senile Purpura
A NA study, sponsored by Siperstein Dermatology.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03690375 is a NA study that has completed, run by Siperstein Dermatology. The registered enrollment target is 10 participants.
The verdict
NCT03690375, a NA study, has completed, sponsored by Siperstein Dermatology.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
There will be five subjects over the age of 65, each with at least one ecchymotic lesion on each arm measuring at least one cm, and five control subjects under the age of 35, both who will be randomized to undergo 4 Sciton Broad Band Light (BBL) treatments on either their left or right arm one week apart. Subjects will fill out questionnaires, have pictures of their lower arms taken, and will be graded and measured by evaluators regarding the number and size of their ecchymoses as well as side effects such as blistering, pain, erythema, and swelling. One day after their 4th treatment on each arm, subjects will have biopsies done to be analyzed for changes in histology and gene expression. The subjects will follow up 1 month after their last treatments for final pictures of their lower arms and evaluations.
Interventions
- DEVICE Broad Band Light (BBL)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-08-27 |
| Est. Completion | 2019-11-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03690375
The ClinicalTrials.gov registry entry for NCT03690375 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Siperstein Dermatology, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Broad Band Light (BBL) is the first listed.
NCT03690375 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03690375 about?
NCT03690375 is a clinical study titled "Broad Band Light for the Treatment and Prevention of Senile Purpura". There will be five subjects over the age of 65, each with at least one ecchymotic lesion on each arm measuring at least one cm, and five control subjects under the age of 35, both who will be randomized to undergo 4 Sciton Broad Band Light (BBL) treatments on either their left or right arm one week ...
What is the current status of trial NCT03690375?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2018-08-27. Estimated completion is 2019-11-11.
What interventions are being tested in trial NCT03690375?
The interventions under investigation include: Broad Band Light (BBL) (DEVICE).
Who is sponsoring clinical trial NCT03690375?
This trial is sponsored by Siperstein Dermatology, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.